Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
Arno R. Bourgonje, Martin Feelisch, Klaas Nico Faber, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 11, pp. 1034-1046
Open Access | Times Cited: 254

Showing 1-25 of 254 citing articles:

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
Francesca Silvagno, Annamaria Vernone, Gianpiero Pescarmona
Antioxidants (2020) Vol. 9, Iss. 7, pp. 624-624
Open Access | Times Cited: 207
Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke
Guanning Huang, Jiankun Zang, Lizhen He, et al.
ACS Nano (2021) Vol. 16, Iss. 1, pp. 431-452
Closed Access | Times Cited: 145
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease
Chengxin Shi, Jianati Dawulieti, Feiyu Shi, et al.
Science Advances (2022) Vol. 8, Iss. 4
Open Access | Times Cited: 141
Biocatalytic and Antioxidant Nanostructures for ROS Scavenging and Biotherapeutics
Liyun Wang, Bihui Zhu, Yuting Deng, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 31
Closed Access | Times Cited: 136
Design of Diselenide-Bridged Hyaluronic Acid Nano-antioxidant for Efficient ROS Scavenging to Relieve Colitis
Jiaqi Xu, Tianjiao Chu, Tingting Yu, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 13037-13048
Closed Access | Times Cited: 132
Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
Jun Liu, Yixin Wang, William J. Heelan, et al.
Science Advances (2022) Vol. 8, Iss. 45
Open Access | Times Cited: 119
Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease
Dipak Kumar Sahoo, Romy M. Heilmann, Biswaranjan Paital, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 109
Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy
Xiaohua Pan, Qing Zhu, Li‐Long Pan, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108176-108176
Closed Access | Times Cited: 107
Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice
Fan Wan, Ruqing Zhong, Mengyu Wang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 104
Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study
Shu Xu, Xiaozhi Li, Shenghong Zhang, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis
Yana Ma, Wenhui Gao, Yujie Zhang, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 5, pp. 6358-6369
Closed Access | Times Cited: 86
Postbiotics and Their Health Modulatory Biomolecules
Emma C. Scott, Kim De Paepe, Tom Van de Wiele
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1640-1640
Open Access | Times Cited: 77
Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics
Yana Ma, Jingjie Zhao, Liangliang Cheng, et al.
Carbon (2023) Vol. 204, pp. 526-537
Closed Access | Times Cited: 66
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
Lijun Ning, Yilu Zhou, Han Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 62
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Yameng Cao, Kai Cheng, Mei Yang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets
Arno R. Bourgonje, Damian Klóska, Anna Grochot-Przęczek, et al.
Redox Biology (2023) Vol. 60, pp. 102603-102603
Open Access | Times Cited: 58
Oxidative stress: The nexus of obesity and cognitive dysfunction in diabetes
Huimin Li, Jing Ren, Yusi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 51
Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ
María Eugenia Inda, Miguel Jiménez, Qijun Liu, et al.
Nature (2023) Vol. 620, Iss. 7973, pp. 386-392
Closed Access | Times Cited: 44
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
Sem Geertsema, Arno R. Bourgonje, Raphael R. Fagundes, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 10, pp. 830-842
Open Access | Times Cited: 44
An Engineered Butyrate-Derived Polymer Nanoplatform as a Mucosa-Healing Enhancer Potentiates the Therapeutic Effect of Magnolol in Inflammatory Bowel Disease
Fan Xi, Zhuangzhuang Zhang, Wenxia Gao, et al.
ACS Nano (2023) Vol. 18, Iss. 1, pp. 229-244
Closed Access | Times Cited: 41
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 30
Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 24
Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota
Shaqed Carasso, Rawan Zaatry, Haitham Hajjo, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 3, pp. 322-334.e9
Open Access | Times Cited: 20
Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease
Zhangpeng Shi, Xiaohong Li, Jufeng Chen, et al.
Bioactive Materials (2024) Vol. 35, pp. 167-180
Open Access | Times Cited: 19
Mitochondrial function and gastrointestinal diseases
Parsa Haque, Neeraj Kapur, Terrence A. Barrett, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 537-555
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top